For years, people with obesity, other conditions (like diabetes, high blood pressure, and fatty liver disease) have been treated one at a time. But newer evidence-based treatments work very differently: they improve health across the entire cardiometabolic system rather than addressing just one issue.
Treating More Than One Condition at a Time
Experts now understand that obesity medications don’t simply lower A1C or support weight loss. They have far broader effects. As cardiologist Dr. Subodh Verma explains, “I prescribe these agents for cardiovascular protection. These are vascular drugs. They’re disease modifying drugs.”
In addition to heart protection, they also have metabolic benefits. As he notes, these treatments “offer benefits for weight reduction and benefits on A1C control… We believe these are metabolic modulators, we believe they’re vascular protective.”
This means the medications target the underlying cardiometabolic risk that drives multiple conditions at once. By improving overall metabolic health, “you will also observe that you will have a reduction in weight and sugar.”
Why These Treatments Matter
Cardiometabolic syndrome—which includes heart disease, fatty liver disease, kidney disease, high blood sugar, and excess weight—is complex. Traditional one-problem-at-a-time approaches often fall short. But these newer medications offer, in Dr. Verma’s words, “one solution for a multifaceted problem.”
That’s why these therapies are used not only for diabetes or weight management, but also for preventing long-term complications across the cardiometabolic system.
What Happens If Treatment Stops?
One common question is whether the benefits last if someone stops treatment. Obesity specialist Dr. Megha Poddar explains that health improvements are closely linked to staying on the medication.
She notes that when someone is taking one of these medications and seeing improvements in markers like inflammation, cholesterol, or liver health, “if you stop that medication, will those benefits go away? So far, what we’ve seen… is that in general, if you stop the medication, those inflammatory markers, those cardiac markers do go back up to baseline.”
The same pattern shows up in blood pressure and cholesterol: “When you stop those medications, we see that the blood pressure goes up, the cholesterol goes up.” Her conclusion is clear: “the protection is no longer there if you’re no longer on treatment.”
A Comprehensive Approach to Health
Because these therapies treat the core metabolic dysfunction—rather than one isolated symptom—they offer multiple benefits at once:
- Better blood sugar
- Lower inflammation
- Improved liver health
- Reduced heart and kidney risk
- Meaningful weight reduction
The Bottom Line
These newer, evidence-based treatments are helping people improve their whole health—not just their blood sugar or their weight. Because they work on the root causes of cardiometabolic disease, they can support the heart, liver, kidneys, and metabolism. For anyone dealing with conditions like diabetes, obesity, or fatty liver disease, these treatments offer a powerful way to protect long-term health and feel better overall.
Diet and exercise alone aren’t enough to help many people reach a healthier weight. Medical treatments are needed to address the biological changes happening in our bodies that can drive weight regain. To find a physician near you who specializes in weight management, click here.
This article was sponsored by Novo Nordisk Canada. All content is created independently by My Weight – What To Know with no influence from Novo Nordisk.
